Enhancing Omicron Sublineage Neutralization: Insights From Bivalent and Monovalent COVID-19 Booster Vaccines and Recent SARS-CoV-2 Omicron Variant InfectionsINFLUENZA AND OTHER RESPIRATORY VIRUSESIF4.22024-10-080OAAI
Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosisFRONTIERS IN IMMUNOLOGYIF5.92023-03-245OAAI
Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infectionCELL REPORTS MEDICINEIF10.62022-10-0122OAAI
Clinicopathological Characteristics of Inflammatory Myositis Induced by COVID-19 Vaccine (Pfizer-BioNTech BNT162b2): A Case ReportJOURNAL OF KOREAN MEDICAL SCIENCEIF2.32022-01-0118OAAI
Splenic uptake on FDG PET/CT correlates with Kikuchi-Fujimoto disease severitySCIENTIFIC REPORTSIF3.92021-05-258OAAI
Profiles of Extrapulmonary Nontuberculous Mycobacteria Infections and Predictors for Species: A Multicenter Retrospective StudyPATHOGENSIF3.32020-11-1411OAAI
Viable SARS-CoV-2 in various specimens from COVID-19 patientsCLINICAL MICROBIOLOGY AND INFECTIONIF8.52020-11-01161OAAI
Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: a mathematical modelling studySCIENTIFIC REPORTSIF3.92020-09-0311OAAI
A Modified Simple Scoring System Using the Red Blood Cell Distribution Width, Delta Neutrophil Index, and Mean Platelet Volume-to-Platelet Count to Predict 28-Day Mortality in Patients With SepsisJOURNAL OF INTENSIVE CARE MEDICINEIF2.12020-06-0915PREAI
Risk Factors for Mortality in Patients with Elizabethkingia Infection and the Clinical Impact of the Antimicrobial Susceptibility Patterns of Elizabethkingia SpeciesJOURNAL OF CLINICAL MEDICINEIF2.92020-05-1223OAAI
Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344)BIOCHEMICAL PHARMACOLOGYIF5.62011-04-0137PREAI